Takeda Pharmaceutical Shares Slump After It Books 2Q Loss, Cuts Profit Guidance - MarketWatch
| TKD Stock | EUR 25.01 0.12 0.48% |
Roughly 54% of Takeda Pharmaceutical's investor base is interested to short. The analysis of current outlook of investing in Takeda Pharmaceutical suggests that many traders are impartial regarding Takeda Pharmaceutical's prospects. The current market sentiment, together with Takeda Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Takeda Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Takeda Pharmaceutical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Takeda daily returns and investor perception about the current price of Takeda Pharmaceutical as well as its diversification or hedging effects on your existing portfolios.
Takeda |
Takeda Pharmaceutical Shares Slump After It Books 2Q Loss, Cuts Profit Guidance MarketWatch
Read at news.google.com
 |
Takeda Pharmaceutical Fundamental Analysis
We analyze Takeda Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Takeda Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Takeda Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Takeda Pharmaceutical is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Takeda Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Takeda Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Takeda Pharmaceutical could also be used in its relative valuation, which is a method of valuing Takeda Pharmaceutical by comparing valuation metrics with similar companies.
Peers
Takeda Pharmaceutical Related Equities
| 3GH | KAUFMAN ET | 3.25 | ||||
| 47U | QUEEN S | 2.17 | ||||
| ROW | Texas Roadhouse | 1.78 | ||||
| E6Q | Gold Road | 0.83 | ||||
| ZFI1 | ZURICH INSURANCE | 0.70 | ||||
| QBE | QBE Insurance | 0.87 | ||||
| 2OX | Goosehead Insurance | 4.56 |
Complementary Tools for Takeda Stock analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |